| JXSL1700008 | avelumab | avelumab | Other | Biological Products | Import Drug Application | 2017-02-20 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | Certificate Issued | 2017-07-03 | view |
| JXSL1600011 | avelumab | avelumab | Other | Biological Products | Import Drug Application | 2016-03-23 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | Certificate Issued | 2016-11-16 | view |
| JXHL2100087 | Berzosertib注射液 | berzosertib | Injection | Chemical Drugs(1) | Import Drug Application | 2021-03-12 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Healthcare KGaA | In Review | 2021-03-12 | view |
| JXSL2000002 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2020-01-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Healthcare KGaA | In Review | 2020-01-10 | view |
| JXSB2000030 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products(1) | Supplementary Application | 2020-10-14 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Serono SpA;Merck Healthcare KGaA | In Review | 2020-10-13 | view |
| JXSL1900155 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2020-01-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Healthcare KGaA | In Review | 2020-01-10 | view |
| JXSL1900054 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2019-06-12 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | In Review | 2019-06-11 | view |
| JYSB2000179 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Supplementary Application | 2020-05-16 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Baxter Oncology GmbH;Merck KGaA | In Review | 2020-05-15 | view |
| JXSL1800051 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2018-11-12 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | In Review | 2018-11-09 | view |
| JXSL1900006 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2019-02-02 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | In Review | 2019-02-01 | view |
| JYSB2000112 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Supplementary Application | 2020-04-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Baxter Oncology GmbH;Merck Healthcare KGaA | In Review | 2020-04-10 | view |
| JXHL1300274 | MSC2156119J | tepotinib hydrochloride | Other | Chemical Drugs | Import Drug Application | 2013-08-07 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | Certificate Issued | 2014-10-23 | view |
| JXHL1300275 | MSC2156119J | tepotinib hydrochloride | Other | Chemical Drugs | Import Drug Application | 2013-07-26 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | Certificate Issued | 2014-10-23 | view |
| JXHL1300337 | MSC2156119J | tepotinib hydrochloride | Other | Chemical Drugs | Import Drug Application | 2013-09-02 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | Certificate Issued | 2014-11-24 | view |
| JXHL1300338 | MSC2156119J | tepotinib hydrochloride | Other | Chemical Drugs | Import Drug Application | 2013-08-31 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | Certificate Issued | 2014-11-24 | view |
| JXSL2000200 | Pergoveris Powder and solvent for solution for injection | follitropin alfa;lutropin alfa | Lyophilized | Biological Products(3.1) | Import Drug Application | 2020-11-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Europe BV | In Review | 2020-11-10 | view |
| JXSL2000203 | Pergoveris Solution for injection | follitropin alfa;lutropin alfa | Injection | Biological Products(3.1) | Import Drug Application | 2020-11-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Europe BV | In Review | 2020-11-10 | view |
| JXSL2000202 | Pergoveris Solution for injection | follitropin alfa;lutropin alfa | Injection | Biological Products(3.1) | Import Drug Application | 2020-11-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Europe BV | In Review | 2020-11-10 | view |
| JXSL2000201 | Pergoveris Solution for injection | follitropin alfa;lutropin alfa | Injection | Biological Products(3.1) | Import Drug Application | 2020-11-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Europe BV | In Review | 2020-11-10 | view |
| JYHB2000563 | Tepotinib片 | tepotinib hydrochloride | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-05-16 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Healthcare KGaA | In Review | 2020-05-15 | view |
